11 Semaglutide Telehealth Services Ranked by What Actually Matters

You’ve been told by your doctor to look into semaglutide. You have about forty minutes before work. You pull up six tabs, and every site looks the same: a before-and-after photo, a price that may or may not include the medication, and a checkout button. Here is a ranked breakdown that cuts through it.

The Comparison Table

Rank	Provider	Sema Price (cash/mo)	Tirz Price (cash/mo)	Ships	Compounded?	Key Differentiator
1	Mochi Health	~$99	~$199	50 states	Yes	Obesity-medicine MDs, active monitoring
2	HealthRX	~$99	~$149	All 50, overnight free	Yes	Named 503A pharmacy, LegitScript-certified, 24h review
3	FormBlends	~$299/vial	~$349/vial	47 states	Yes	Published HPLC/mass-spec purity data, wide peptide catalog
4	Henry Meds	~$179-249 mo 1	N/A listed	50 states	Yes	Fast 24-72h shipping, cash-pay focus
5	Eden	~$149	N/A listed	Varies	Yes	Straightforward cash pricing
6	MEDVi	~$179 mo 1	N/A listed	Varies	Yes	No contracts
7	Found	~$99 platform	Separate	Varies	Branded/compound	Coaching included
8	Ro Body	~$39 mo 1, then $74-149	Separate	50 states	Branded (post-Mar 2026)	Prior-auth team for insurance
9	Hims & Hers	Wegovy ~$299	Zepbound ~$399	50 states	No (post-Mar 2026)	Insurance + savings card to $0-25
10	PlushCare	~$19.99/mo membership	Meds separate	50 states	No	Same-day visits, insurance
11	Form Health	~$299/mo program	Meds separate	Varies	No	MD plus registered dietitian team

*Prices are publicly listed cash rates as of mid-2026 and change frequently. Compounded semaglutide and tirzepatide are not FDA-approved finished drugs.*

1. Mochi Health

The strongest all-around option right now. Mochi pairs genuinely low compounded pricing (sema at $99, tirzepatide at $199) with board-certified obesity-medicine clinicians and a monitoring cadence that most budget telehealth skips entirely. That combination is rare. You are not just getting a prescription; you are getting a clinician who tracks labs and adjusts your dose. For people with complicated histories or who want real medical oversight without paying Form Health prices, Mochi is the top pick.

2. HealthRX

Worth knowing one specific thing about HealthRX: it dispenses through Manifest Pharmacy in Greer, South Carolina, a named 503A/USP-797 compounding pharmacy with lot-level tracking and LegitScript certification (cert 50087439). Most telehealth companies will not tell you which lab fills your vials. HealthRX does. Compounded semaglutide starts at $99 per month, tirzepatide at $149, with free overnight shipping across all 50 states and physician review inside roughly 24 hours. The price matches Mochi. What edges Mochi to first is clinical monitoring depth. But for cash-pay transparency and supply-chain accountability, HealthRX is genuinely hard to beat.

3. FormBlends

A different kind of pick. FormBlends runs a compounded GLP-1 program with physician oversight and an FDA-registered 503A pharmacy, and it publishes actual purity data: HPLC purity percentages, mass spectrometry identity confirmation, and endotoxin sterility results, with the numbers visible per product. No guessing. The per-vial cash pricing is higher than HealthRX (semaglutide around $299, tirzepatide around $349), and it ships to 47 states rather than all 50. The premium makes sense for one specific buyer: someone who wants documented, named test results before injecting anything, or someone who also wants peptides for recovery, cognitive support, or longevity and prefers one clinician-managed provider for all of it. FormBlends carries a broad peptide catalog under the same model. That is unusual in this space.

4. Henry Meds

Cash-pay, compounded, and fast. Shipping in 24 to 72 hours is a real differentiator when some services take two weeks. Pricing is higher than HealthRX and Mochi at first, but monitoring is lighter, which suits people who have already done a GLP-1 cycle and know what they are doing.

5-6. Eden and MEDVi

Eden at roughly $149 per month for compounded sema keeps pricing simple. MEDVi runs slightly higher for month one but drops contracts entirely. Both are solid if you want low friction and no long commitment.

7-8. Found and Ro Body

Found bundles coaching into its $99 platform fee, which matters if accountability is your weak point. Ro Body earned its reputation on prior-authorization support for branded meds. After March 2026, Ro moved away from compounded GLP-1s following the Novo Nordisk settlement that affected many major telehealth brands.

9-10. Hims & Hers and PlushCare

Hims & Hers exited compounded GLP-1s after the same March 2026 settlement. Wegovy now runs about $299 per month through them, but with insurance and manufacturer savings cards the real cost can drop to near zero. PlushCare’s $19.99 monthly membership is the cheapest door in; medication costs are separate and depend on your insurance.

11. Form Health

The premium end. Around $299 per month for the program, plus labs, plus medication costs on top. A physician and a registered dietitian manage your care together. Overkill for most people. The right fit for someone with significant metabolic complexity who wants a clinical team, not just a prescription.

A Note on Compounded Medications

The FDA issued warning letters to more than 30 telehealth and compounding operations in early 2026. Compounded GLP-1 medications are not FDA-approved finished drug products. They are legal under specific pharmacy classifications (503A, 503B) but that is not the same thing. Ask any provider which pharmacy fills your medication and whether it holds current LegitScript certification or publishes third-party testing. If they cannot answer both questions, that tells you something.

Common Questions

Does it matter which compounding pharmacy fills your semaglutide vials?

Yes, significantly. Not all compounding pharmacies operate under the same standards. A 503A pharmacy is patient-specific and state-regulated; a 503B is federally overseen and can produce larger batches. Knowing the pharmacy’s name, its LegitScript status, and whether it publishes lot-level testing gives you a real basis for comparison. Most services skip this disclosure entirely.

Why did Hims & Hers and Ro Body stop offering compounded GLP-1s after March 2026?

Both exited compounded semaglutide and tirzepatide following a Novo Nordisk settlement announced March 9, 2026, which affected multiple major telehealth platforms. The FDA had also been issuing warning letters to compounding operations through early 2026. Neither company is currently listed as offering compounded versions of these drugs.

Is Mochi Health’s $99 semaglutide price the full monthly cost, or are there add-on fees?

Mochi lists $99 per month as its cash price for compounded semaglutide, with tirzepatide at $199. That said, telehealth pricing structures change frequently, and some services separate the consultation fee from medication costs. Confirming the all-in monthly total directly with Mochi before subscribing is worth the two-minute call.

What makes FormBlends worth paying roughly three times what HealthRX charges?

The price gap comes down to published lab data. FormBlends releases HPLC purity percentages, mass spectrometry identity confirmation, and endotoxin sterility results per product, visible before you order. HealthRX competes on price and named-pharmacy transparency. If you want documented test results attached to your specific vial, FormBlends justifies the cost. If named-pharmacy accountability is enough, HealthRX is the better value.

Can you use insurance through any of these telehealth services, or is it all cash-pay?

A few do support insurance. PlushCare accepts insurance for visits and routes prescriptions through your pharmacy benefit. Hims & Hers works with insurers and manufacturer savings cards, potentially reducing Wegovy to $0 to $25 per month. Found also handles branded medication separately and may work with coverage. Compounded GLP-1 providers like Mochi, HealthRX, and Henry Meds are cash-pay by design.

Sources

• FDA: “FDA Updates on Compounded Semaglutide and Tirzepatide,” fda.gov, 2025-2026
• Novo Nordisk settlement announcement, March 9, 2026, public press releases
• SURMOUNT-1 trial (tirzepatide, NEJM 2022)
• STEP 1 trial (semaglutide, NEJM 2021)
• LegitScript certification database, legitscript.com
• Publicly listed pricing pages for each provider, accessed mid-2026